LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset (ID:20242)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | CP724714 | 0.37 | uM | LJP5 | 72 | hr | 1235 | 4612 | 4513 | 1.0219 | 1.0302 |
MDA-MB-231 | CP466722 | 0.37 | uM | LJP5 | 72 | hr | 1235 | 3084 | 4513 | 0.6833 | 0.5639 |
MDA-MB-231 | Crizotinib | 0.37 | uM | LJP5 | 72 | hr | 1235 | 4053 | 4513 | 0.8981 | 0.8597 |
MDA-MB-231 | Momelotinib | 0.37 | uM | LJP5 | 72 | hr | 1235 | 2970 | 4513 | 0.6581 | 0.5292 |
MDA-MB-231 | Dasatinib | 0.37 | uM | LJP5 | 72 | hr | 1235 | 790 | 4513 | 0.1751 | -0.1360 |
MDA-MB-231 | Dasatinib | 0.37 | uM | LJP6 | 72 | hr | 1235 | 771 | 4513 | 0.1709 | -0.1418 |
MDA-MB-231 | Dovitinib | 0.37 | uM | LJP5 | 72 | hr | 1235 | 2602 | 4513 | 0.5766 | 0.4169 |
MDA-MB-231 | Enzastaurin | 0.37 | uM | LJP5 | 72 | hr | 1235 | 4829 | 4513 | 1.0699 | 1.0962 |
MDA-MB-231 | Erlotinib | 0.37 | uM | LJP5 | 72 | hr | 1235 | 4306 | 4513 | 0.9541 | 0.9368 |
MDA-MB-231 | Foretinib | 0.37 | uM | LJP5 | 72 | hr | 1235 | 1389 | 4513 | 0.3079 | 0.0469 |
MDA-MB-231 | R406 | 0.37 | uM | LJP6 | 72 | hr | 1235 | 4314 | 4513 | 0.9559 | 0.9393 |
MDA-MB-231 | Pictilisib | 0.37 | uM | LJP6 | 72 | hr | 1235 | 3275 | 4513 | 0.7257 | 0.6222 |
MDA-MB-231 | Gefitinib | 0.37 | uM | LJP6 | 72 | hr | 1235 | 4443 | 4513 | 0.9845 | 0.9787 |
MDA-MB-231 | Geldanamycin | 0.37 | uM | LJP5 | 72 | hr | 1235 | 944 | 4513 | 0.2092 | -0.0890 |
MDA-MB-231 | Geldanamycin | 0.37 | uM | LJP6 | 72 | hr | 1235 | 876 | 4513 | 0.1942 | -0.1096 |
MDA-MB-231 | GSK1059615 | 0.37 | uM | LJP5 | 72 | hr | 1235 | 4112 | 4513 | 0.9112 | 0.8777 |
MDA-MB-231 | GSK1059615 | 0.37 | uM | LJP6 | 72 | hr | 1235 | 3933 | 4513 | 0.8715 | 0.8231 |
MDA-MB-231 | GSK1904529A | 0.37 | uM | LJP6 | 72 | hr | 1235 | 4087 | 4513 | 0.9055 | 0.8698 |
MDA-MB-231 | Omipalisib | 0.37 | uM | LJP6 | 72 | hr | 1235 | 1155 | 4513 | 0.2560 | -0.0245 |
MDA-MB-231 | GSK 690693 | 0.37 | uM | LJP5 | 72 | hr | 1235 | 4346 | 4513 | 0.9630 | 0.9491 |
MDA-MB-231 | GW843682X | 0.37 | uM | LJP6 | 72 | hr | 1235 | 2103 | 4513 | 0.4659 | 0.2645 |
MDA-MB-231 | HG-5-113-01 | 0.37 | uM | LJP5 | 72 | hr | 1235 | 3553 | 4513 | 0.7873 | 0.7071 |
MDA-MB-231 | HG-5-88-01 | 0.37 | uM | LJP6 | 72 | hr | 1235 | 3873 | 4513 | 0.8582 | 0.8048 |
MDA-MB-231 | Imatinib | 0.37 | uM | LJP6 | 72 | hr | 1235 | 4366 | 4513 | 0.9673 | 0.9550 |
MDA-MB-231 | JNK-9L | 0.37 | uM | LJP6 | 72 | hr | 1235 | 2281 | 4513 | 0.5054 | 0.3189 |